The importance of 5-HT4R-directed synaptic therapies was emphasized by our bioinformatics results showing that the 5-HT4R serotonergic pathway is downregulated predominantly in neurons, reflecting the occurrence of serotonergic degeneration in AD brain (Smith et al., 2017). The gene discussed is HTR4; the disease is Alzheimer disease.